Long-range PCR and next-generation sequencing of BRCA1 and BRCA2 in breast cancer

Journal of Molecular Diagnostics

Volumn 14, Issue 5, 2012, Pages 467-475

  Ozcelik, Hilmi ^a,b,c   Shi, Xuejiang ^a   Chang, Martin C ^b,c   Tram, Eric ^a,c   Vlasschaert, Matt ^b   Di Nicola, Nando ^b   Kiselova, Anna ^b   Yee, Denise ^b   Goldman, Aaron ^a   Dowar, Mark ^a   Sukhu, Balram ^b   Kandel, Rita ^a,b,c   Siminovitch, Kathy ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

ARTICLE; BRCA2 GENE; BREAST CANCER; COST BENEFIT ANALYSIS; EXON; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GENE INACTIVATION; GENETIC VARIABILITY; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NEXT GENERATION SEQUENCING; NUCLEOTIDE SEQUENCE; ONCOGENE; POLYMERASE CHAIN REACTION; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS;

BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84865070623     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2012.03.006     Document Type: Article

References (32)

1. R. Wooster, G. Bignell, J. Lancaster, S. Swift, S. Seal, J. Mangion, N. Collins, S. Gregory, C. Gumbs, G. Micklem Identification of the breast cancer susceptibility gene BRCA2 Nature 378 1995 789 792
2. Y. Miki, J. Swensen, D. Shattuck-Eidens, P.A. Futreal, K. Harshman, S. Tavtigian, Q. Liu, C. Cochran, L.M. Bennett, W. Ding A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 1994 66 71
3. I.L. Andrulis, H. Anton-Culver, J. Beck, B. Bove, J. Boyd, S. Buys, A. Godwin, J.L. Hopper, F. Li, S.L. Neuhausen, H. Ozcelik, D. Peel, R.M. Santella, M.C. Southey, N.J. van Orsouw, D.J. Venter, J. Vijg, A.S. Whittemore Cooperative Family Registry for Breast Cancer Studies Comparison of DNA-and RNA-based methods for detection of truncating BRCA1 mutations Hum Mutat 20 2002 65 73
4. P.K. Rogan Deeper understanding of unclassified intronic variants and ESEs Hum Mutat 31 2010 V
5. X. Chen, T.T. Truong, J. Weaver, B.A. Bove, K. Cattie, B.A. Armstrong, M.B. Daly, A.K. Godwin Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression Hum Mutat 27 2006 427 435
6. A. Ratanaphan, P. Panomwan, B. Canyuk, T. Maipang Identification of novel intronic BRCA1 variants of uncertain significance in a Thai hereditary breast cancer family J Genet 90 2011 327 331
7. F. Pagani, F.E. Baralle Genomic variants in exons and introns: identifying the splicing spoilers Nat Rev Genet 5 2004 389 396
8. D. Baralle, M. Baralle Splicing in action: assessing disease causing sequence changes J Med Genet 42 2005 737 748
9. S.Y. Ying, S.L. Lin Intron-mediated RNA interference and microRNA biogenesis Methods Mol Biol 487 2009 387 413
10. K.M. Frizzell, W.L. Kraus PARP inhibitors and the treatment of breast cancer: beyond BRCA1/2? Breast Cancer Res 11 2009 111
11. C.M. Annunziata, S.E. Bates PARP inhibitors in BRCA1/BRCA2 germline mutation carriers with ovarian and breast cancer F1000 Biol Rep 2 2010 10
12. S.L. Chan, T. Mok PARP inhibition in BRCA-mutated breast and ovarian cancers Lancet 376 2010 211 213
13. J. Stebbing, P. Ellis, A. Tutt PARP inhibitors in BRCA1-/BRCA2-associated and triple-negative breast cancers Future Oncol 6 2010 485 486
14. J.A. De Soto, C.X. Deng PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers? Int J Med Sci 3 2006 117 123
15. R.S. Tuma PARP inhibitors: will the new class of drugs match the hype? J Natl Cancer Inst 101 2009 1230 1232
16. D. Inbar-Rozensal, A. Castiel, L. Visochek, D. Castel, F. Dantzer, S. Izraeli, M. Cohen-Armon A selective eradication of human nonhereditary breast cancer cells by phenanthridine-derived polyADP-ribose polymerase inhibitors Breast Cancer Res 11 2009 R78
17. H. Liang, A.R. Tan Iniparib, a PARP1 inhibitor for the potential treatment of cancer, including triple-negative breast cancer IDrugs 13 2010 646 656
18. C. Schroeder, F. Stutzmann, B.H. Weber, O. Riess, M. Bonin High-throughput resequencing in the diagnosis of BRCA1/2 mutations using oligonucleotide resequencing microarrays Breast Cancer Res Treat 122 2010 287 297
19. T. Walsh, M.K. Lee, S. Casadei, A.M. Thornton, S.M. Stray, C. Pennil, A.S. Nord, J.B. Mandell, E.M. Swisher, M.C. King Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing Proc Natl Acad Sci U S A 107 2010 12629 12633
20. D. Summerer, H. Wu, B. Haase, Y. Cheng, N. Schracke, C.F. Stahler, M.S. Chee, P.F. Stahler, M. Beier Microarray-based multicycle-enrichment of genomic subsets for targeted next-generation sequencing Genome Res 19 2009 1616 1621
21. J.E. Morgan, I.M. Carr, E. Sheridan, C.E. Chu, B. Hayward, N. Camm, H.A. Lindsay, C.J. Mattocks, A.F. Markham, D.T. Bonthron, G.R. Taylor Genetic diagnosis of familial breast cancer using clonal sequencing Hum Mutat 31 2010 484 491
22. K. De Leeneer, J. Hellemans, J. De Schrijver, M. Baetens, B. Poppe, W. Van Criekinge, A. De Paepe, P. Coucke, K. Claes Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations Hum Mutat 32 2011 335 344
23. M.A. Innis, D.H. Gelfand, J.J. Sninsky, T.S. White PCR protocols: a guide to methods and applications 1990 Academic Press San Diego
24. H.Y. Yuan, J.J. Chiou, W.H. Tseng, C.H. Liu, C.K. Liu, Y.J. Lin, H.H. Wang, A. Yao, Y.T. Chen, C.N. Hsu FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization Nucleic Acids Res 34 Web Server issue 2006 W635 W641
25. Z. Wang, M.E. Rolish, G. Yeo, V. Tung, M. Mawson, C.B. Burge Systematic identification and analysis of exonic splicing silencers Cell 119 2004 831 845
26. W.G. Fairbrother, R.F. Yeh, P.A. Sharp, C.B. Burge Predictive identification of exonic splicing enhancers in human genes Science 297 2002 1007 1013
27. L. Mamanova, A.J. Coffey, C.E. Scott, I. Kozarewa, E.H. Turner, A. Kumar, E. Howard, J. Shendure, D.J. Turner Target-enrichment strategies for next-generation sequencing Nat Methods 7 2010 111 118
28. Cardiology at the Coast. International Symposium Festschrift in honour of Professor David Wilcken New South Wales, 1820 March 1992 Aust N Z J Med 22 5 Suppl 1992 517 643
29. M. Clendenning, D.D. Buchanan, M.D. Walsh, B. Nagler, C. Rosty, B. Thompson, A.B. Spurdle, J.L. Hopper, M.A. Jenkins, J.P. Young Mutation deep within an intron of MSH2 causes Lynch syndrome Fam Cancer 10 2011 297 301
30. Y.F. Lo, K. Nozu, K. Iijima, T. Morishita, C.C. Huang, S.S. Yang, H.K. Sytwu, Y.W. Fang, M.H. Tseng, S.H. Lin Recurrent deep intronic mutations in the SLC12A3 gene responsible for Gitelman's syndrome Clin J Am Soc Nephrol 6 2011 630 639
31. M. Bovolenta, M. Neri, E. Martoni, A. Urciuolo, P. Sabatelli, M. Fabris, P. Grumati, E. Mercuri, E. Bertini, L. Merlini, P. Bonaldo, A. Ferlini, F. Gualandi Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies BMC Med Genet 11 2010 44
32. K. Homolova, P. Zavadakova, T.K. Doktor, L.D. Schroeder, V. Kozich, B.S. Andresen The deep intronic c. 903+469T>C mutation in the MTRR gene creates an SF2/ASF binding exonic splicing enhancer, which leads to pseudoexon activation and causes the cblE type of homocystinuria Hum Mutat 31 2010 437 444